Literature DB >> 15238138

Fanconi anaemia and leukaemia - clinical and molecular aspects.

Marc Tischkowitz1, Inderjeet Dokal.   

Abstract

Fanconi anaemia (FA) is an autosomal recessive chromosomal instability disorder, which is characterized by congenital abnormalities, defective haemopoiesis and a high risk of developing acute myeloid leukaemia and certain solid tumours. It can be caused by mutations in at least eight different genes. Molecular studies have established that a common pathway exists, both between the FA proteins and other proteins involved in DNA damage repair such as NBS1, ATM, BRCA1 and BRCA2. This review summarizes the general clinical and specific haematological features and the current management of FA. Recent molecular advances will also be discussed in the context of the cellular and clinical FA phenotype, with particular emphasis on the haematological aspects of the condition.

Entities:  

Mesh:

Year:  2004        PMID: 15238138     DOI: 10.1111/j.1365-2141.2004.05023.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  38 in total

1.  Cytokinesis failure occurs in Fanconi anemia pathway-deficient murine and human bone marrow hematopoietic cells.

Authors:  Patrizia Vinciguerra; Susana A Godinho; Kalindi Parmar; David Pellman; Alan D D'Andrea
Journal:  J Clin Invest       Date:  2010-11       Impact factor: 14.808

Review 2.  Mechanisms leading to nonrandom, nonhomologous chromosomal translocations in leukemia.

Authors:  Susanne M Gollin
Journal:  Semin Cancer Biol       Date:  2006-10-26       Impact factor: 15.707

3.  Bax expression and apoptotic cell death in Fanconi anaemia peripheral blood lymphocytes.

Authors:  G A Baruque; M A Bitencourt; R Pasquini; M T L Castelo-Branco; J C Llerena; V M Rumjanek
Journal:  Cell Prolif       Date:  2007-08       Impact factor: 6.831

Review 4.  The Fanconi anemia ID2 complex: dueling saxes at the crossroads.

Authors:  Rebecca A Boisvert; Niall G Howlett
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

5.  Fanconi Anemia with MDS RAEB-2 Rapidly Progressing to AML in a 5-Year-Old Boy.

Authors:  H Rama; Devika Gupta; Tathagata Chatterjee; Srishti Gupta
Journal:  Indian J Hematol Blood Transfus       Date:  2014-07-01       Impact factor: 0.900

Review 6.  Role of genetic susceptibility in development of treatment-related adverse outcomes in cancer survivors.

Authors:  Smita Bhatia
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-10       Impact factor: 4.254

7.  Loss of Faap20 Causes Hematopoietic Stem and Progenitor Cell Depletion in Mice Under Genotoxic Stress.

Authors:  Tingting Zhang; Andrew F Wilson; Abdullah Mahmood Ali; Satoshi H Namekawa; Paul R Andreassen; Amom Ruhikanta Meetei; Qishen Pang
Journal:  Stem Cells       Date:  2015-05-25       Impact factor: 6.277

8.  Knockdown of Fanconi anemia genes in human embryonic stem cells reveals early developmental defects in the hematopoietic lineage.

Authors:  Asmin Tulpule; M William Lensch; Justine D Miller; Karyn Austin; Alan D'Andrea; Thorsten M Schlaeger; Akiko Shimamura; George Q Daley
Journal:  Blood       Date:  2010-01-20       Impact factor: 22.113

9.  Fetal origins of hematopoietic failure in a murine model of Fanconi anemia.

Authors:  Ashley N Kamimae-Lanning; Natalya A Goloviznina; Peter Kurre
Journal:  Blood       Date:  2013-01-11       Impact factor: 22.113

10.  In vitro effect of fludarabine, cyclophosphamide, and cytosine arabinoside on chromosome breakage in Fanconi anemia patients: relevance to stem cell transplantation.

Authors:  Miharu Yabe; Hiromasa Yabe; Satoshi Hamanoue; Hiroyasu Inoue; Masae Matsumoto; Takashi Koike; Hiroyuki Ishiguro; Tsuyoshi Morimoto; Satoshi Arakawa; Toshio Ohshima; Atsuko Masukawa; Hayato Miyachi; Takayuki Yamashita; Shunichi Katob
Journal:  Int J Hematol       Date:  2007-05       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.